Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: A meta-analysis

Oncotarget

Volumn 8, Issue 51, 2017, Pages 89119-89129

  Chen, Yuxin ^a   Jia, Bei ^b   Liu, Yong ^a   Huang, Rui ^b   Chen, Junhao ^a   Wu, Chao ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Meta analysis; Risk analysis; Severe fever with thrombocytopenia syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; LACTATE DEHYDROGENASE; RIBAVIRIN;

AGING; ARTICLE; DISEASE COURSE; FATALITY; HUMAN; PARTIAL THROMBOPLASTIN TIME; PROGNOSIS; RISK FACTOR; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; VIRUS LOAD;

EID: 85031942413     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.19163     Document Type: Article

References (35)

1. Shin J, Kwon D, Youn SK, Park JH. Characteristics and Factors Associated with Death among Patients Hospitalized for Severe Fever with Thrombocytopenia Syndrome, South Korea, 2013. Emerg Infect Dis. 2015; 21:1704-1710.
2. McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, Batten BC, Albarino CG, Zaki SR, Rollin PE, Nicholson WL, Nichol ST. A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012; 367:834-841.
3. Kato H, Yamagishi T, Shimada T, Matsui T, Shimojima M, Saijo M, Oishi K, group-Japan Ser. Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013-2014. PLoS One. 2016; 11:e0165207.
4. Li Z, Bao C, Hu J, Liu W, Wang X, Zhang L, Ji Z, Feng Z, Li L, Shen A, Liu X, Zhao H, Tan W, et al. Ecology of the Tick-Borne Phlebovirus Causing Severe Fever with Thrombocytopenia Syndrome in an Endemic Area of China. PLoS Negl Trop Dis. 2016; 10:e0004574.
5. Niu G, Li J, Liang M, Jiang X, Jiang M, Yin H, Wang Z, Li C, Zhang Q, Jin C, Wang X, Ding S, Xing Z, et al. Severe fever with thrombocytopenia syndrome virus among domesticated animals, China. Emerg Infect Dis. 2013; 19:756-763.
6. Gai Z, Liang M, Zhang Y, Zhang S, Jin C, Wang SW, Sun L, Zhou N, Zhang Q, Sun Y, Ding SJ, Li C, Gu W, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis. 2012; 54:249-252.
7. Bao CJ, Qi X, Wang H. A novel bunyavirus in China. N Engl J Med. 2011; 365:862-863. author reply 864-865.
8. Bao CJ, Guo XL, Qi X, Hu JL, Zhou MH, Varma JK, Cui LB, Yang HT, Jiao YJ, Klena JD, Li LX, Tao WY, Li X, et al. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis. 2011; 53:1208-1214.
9. Tang X, Wu W, Wang H, Du Y, Liu L, Kang K, Huang X, Ma H, Mu F, Zhang S, Zhao G, Cui N, Zhu BP, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. J Infect Dis. 2013; 207:736-739.
10. Liu K, Zhou H, Sun RX, Yao HW, Li Y, Wang LP, Mu D, Li XL, Yang Y, Gray GC, Cui N, Yin WW, Fang LQ, et al. A national assessment of the epidemiology of severe fever with thrombocytopenia syndrome, China. Sci Rep. 2015; 5:9679.
11. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, Qu J, Li Q, Zhang YP, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011; 364:1523-1532.
12. Liu Q, He B, Huang SY, Wei F, Zhu XQ. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis. 2014; 14:763-772.
13. Ding YP, Liang MF, Ye JB, Liu QH, Xiong CH, Long B, Lin WB, Cui N, Zou ZQ, Song YL, Zhang QF, Zhang S, Liu YZ, et al. Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection. Clin Microbiol Infect. 2014; 20:O870-878.
14. Deng B, Zhou B, Zhang S, Zhu Y, Han L, Geng Y, Jin Z, Liu H, Wang D, Zhao Y, Wen Y, Cui W, Zhou Y, et al. Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PLoS One. 2013; 8:e80802.
15. Gai ZT, Zhang Y, Liang MF, Jin C, Zhang S, Zhu CB, Li C, Li XY, Zhang QF, Bian PF, Zhang LH, Wang B, Zhou N, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis. 2012; 206:1095-1102.
16. Deng B, Zhang S, Geng Y, Zhang Y, Wang Y, Yao W, Wen Y, Cui W, Zhou Y, Gu Q, Wang W, Wang Y, Shao Z, et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS One. 2012; 7:e41365.
17. Zhang W, Li M, Xiong S, Wang H, Xiong Y, Li M, Lu M, Yang D, Peng C, Zheng X. Decreased myeloid dendritic cells indicate a poor prognosis in patients with severe fever with thrombocytopenia syndrome. Int J Infect Dis. 2017; 54:113-120.
18. Choi SJ, Park SW, Bae IG, Kim SH, Ryu SY, Kim HA, Jang HC, Hur J, Jun JB, Jung Y, Chang HH, Kim YK, Yi J, et al. Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013-2015. PLoS Negl Trop Dis. 2016; 10:e0005264.
19. Xiong S, Zhang W, Li M, Xiong Y, Li M, Wang H, Yang D, Peng C, Zheng X. A simple and practical score model for predicting the mortality of severe fever with thrombocytopenia syndrome patients. Medicine (Baltimore). 2016; 95:e5708.
20. Cui N, Bao XL, Yang ZD, Lu QB, Hu CY, Wang LY, Wang BJ, Wang HY, Liu K, Yuan C, Fan XJ, Wang Z, Zhang L, et al. Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China. J Clin Virol. 2014; 59:12-17.
21. Li J, Han Y, Xing Y, Li S, Kong L, Zhang Y, Zhang L, Liu N, Wang Q, Wang S, Lu S, Huang Z. Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe fever with thrombocytopenia syndrome. PLoS One. 2014; 9:e91679.
22. Sun L, Hu Y, Niyonsaba A, Tong Q, Lu L, Li H, Jie S. Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome. Clin Exp Med. 2014; 14:389-395.
23. Zhang YZ, He YW, Dai YA, Xiong Y, Zheng H, Zhou DJ, Li J, Sun Q, Luo XL, Cheng YL, Qin XC, Tian JH, Chen XP, et al. Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis. 2012; 54:527-533.
24. Peng C, Wang H, Zhang W, Zheng X, Tong Q, Jie S, Yang D, Zhou Y. Decreased monocyte subsets and TLR4-mediated functions in patients with acute severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2016; 43:37-42.
25. Zhao H SJ, Yan X, Xiong Y, Huang R, Zhang Y, Zhang Z, Song P, Wu C. Clinical characteristics and risk factors for morality of patients with severe fever with thrombocytopenia syndrome. Chin J Clin Infect Dis. 2016; 34:15-18.
26. Ding S, Niu G, Xu X, Li J, Zhang X, Yin H, Zhang N, Jiang X, Wang S, Liang M, Wang X, Yu XJ. Age is a critical risk factor for severe fever with thrombocytopenia syndrome. PLoS One. 2014; 9:e111736.
27. Liu Y, Wu B, Paessler S, Walker DH, Tesh RB, Yu XJ. The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever. Journal of virology. 2014; 88:1781-1786.
28. Zhang XA, Guo CT, Lu QB, Hu JG, Cui N, Yang ZD, Peng W, Liu R, Hu CY, Qin SL, Wang XJ, Ding SJ, Huang DD, et al. The platelet derived growth factor-B polymorphism is associated with risk of severe fever with thrombocytopenia syndrome in Chinese individuals. Oncotarget. 2016; 7:33340-33349. https://doi.org/10.18632/oncotarget.9043.
29. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clinical infectious diseases. 2003; 36:1613-1618.
30. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clinical infectious diseases. 2004; 39:284-287.
31. Bausch DG, Hadi CM, Khan SH, Lertora JJ. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clinical infectious diseases. 2010; 51:1435-1441.
32. Bodur H, Erbay A, Akinci E, Onguru P, Bayazit N, Eren SS, Kubar A. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. International journal of infectious diseases. 2011; 15:e44-47.
33. Guideline for prevention and treatment of severe fever with thrombocytopenia syndrome (2010 version). Chinese Journal of Clinical Infectious Disease. 2011; 4:193-194.
34. Liu W, Lu QB, Cui N, Li H, Wang LY, Liu K, Yang ZD, Wang BJ, Wang HY, Zhang YY, Zhuang L, Hu CY, Yuan C, et al. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis. 2013; 57:1292-1299.
35. Hayasaka D, Nishi K, Fuchigami T, Shiogama K, Onouchi T, Shimada S, Tsutsumi Y, Morita K. 18F-FDG PET imaging for identifying the dynamics of intestinal disease caused by SFTSV infection in a mouse model. Oncotarget. 2016; 7:140-147. https://doi.org/10.18632/oncotarget.6645.